CLINICAL_TRIALS
trial_result
· 2023-10-13
Clinical Trial Update: Melatonin for Adolescent Migraine Prevention Study [Phase 2]
Summary
Phase 2 clinical trial investigating melatonin for prevention of migraine in adolescents was terminated; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amy Gelfand | Conditions: Migraine | Phase 2 | Status: TERMINATED | Results posted: 2023-10-13